SPL 1.02% 9.7¢ starpharma holdings limited

Ann: DEP docetaxel and gemcitabine combination trial commences, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,683 Posts.
    lightbulb Created with Sketch. 5736
    So does this mean they are saving bigger news for the Quarterly ? Two nothing much announcements this week, which could have formed part of the Quarterly IMO - perhaps they didn't want to detract from whatever is in it so they are getting these minor announcements out of the way to leave the focus on something bigger ? I guess I can dream ...
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.